Actuate Therapeutics announced new positive data from its ongoing and fully enrolled randomized Phase 2 trial of elraglusib in...

Read more
By: Stephanie Kawecki On: December 18, 2024 In: GuRu, Portfolio News

GuRu Wireless, Inc., the leading provider of adaptive, long-range wireless energy transfer solutions, announces it has created an Advisory...

Read more
By: Stephanie Kawecki On: December 12, 2024 In: Portfolio News, PteroDynamics

Defence prime Babcock Australasia has signed a Memorandum of Understanding with US-based autonomous aircraft pioneer PteroDynamics Inc to explore...

Read more

Actuate Therapeutics, Inc. (NASDAQ: ACTU) announced that the Company will be added to the Russell 2000® Index as part...

Read more
By: Stephanie Kawecki On: December 2, 2024 In: Portfolio News, Provivi

Godrej Agrovet Limited, a leading agribusiness company in India, has entered into a strategic partnership with US-based Provivi to...

Read more

The Department of Defense today announced the conclusion of the Hypersonic Accelerated Manufactured Prototype Demonstration (Hyper-AMPD!) prize challenge with...

Read more

Actuate Therapeutics, Inc. has received Rare Pediatric Disease Designation from the FDA for elraglusib, a novel GSK-3β inhibitor being...

Read more

Transient Plasma Systems is featured in a recent article highlighting their groundbreaking work in plasma ignition technology, which offers...

Read more
By: Stephanie Kawecki On: October 30, 2024 In: Neuro-Bio, Portfolio News

Neuro-Bio’s CEO, Baroness Susan Greenfield, will lead the inaugural session at the upcoming WeMind International Forum in Barcelona. Susan...

Read more
By: Stephanie Kawecki On: October 24, 2024 In: Portfolio News, PteroDynamics

PteroDynamics Inc., an innovator in autonomous vertical takeoff and landing (VTOL) aircraft systems, and Cornes Technologies Limited, a leading specialist importer and...

Read more